Dr. Louise M. Thurman
Claim this profileIPS Research Company
Studies Alzheimer's Disease
Studies Migraine
5 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Louise M. Thurman is currently running
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Lasmiditan
for Pediatric Migraine
This trial is testing if lasmiditan is safe and effective for children aged 6 to 17 with migraines. The medication aims to block brain signals that cause migraine pain. The study will last several months and may include a few visits. Lasmiditan has been shown to be effective in treating acute migraine attacks in adults and is noted for its safety profile, particularly due to its lack of vasoconstrictive effects.
Recruiting1 award Phase 34 criteria
More about Louise M. Thurman
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Louise M. Thurman has experience with
- Lasmiditan
- Placebo
- Serdexmethylphenidate (SDX) And Dexmethylphenidate (d-MPH)
- Donanemab
- ALZ-801
Breakdown of trials Louise M. Thurman has run
Alzheimer's Disease
Attention Deficit Hyperactivity Disorder (ADHD)
Aggression
Agitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Louise M. Thurman specialize in?
Louise M. Thurman focuses on Alzheimer's Disease and Migraine. In particular, much of their work with Alzheimer's Disease has involved APOE ε4 positive patients, or patients who are undergoing treatment.
Is Louise M. Thurman currently recruiting for clinical trials?
Yes, Louise M. Thurman is currently recruiting for 2 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Louise M. Thurman has studied deeply?
Yes, Louise M. Thurman has studied treatments such as Lasmiditan, Placebo, Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH).
What is the best way to schedule an appointment with Louise M. Thurman?
Apply for one of the trials that Louise M. Thurman is conducting.
What is the office address of Louise M. Thurman?
The office of Louise M. Thurman is located at: IPS Research Company, Oklahoma City, Oklahoma 73106 United States. This is the address for their practice at the IPS Research Company.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.